MeCN (B); flow rate (ν) 1 mL/min; column temperature 30°C; gradient mode (%B): 0−60 min, 10−40%, 60−80 min,
0−60%] to afford 1 (62 mg; t prep. HPLC, 30−34 min) and cosmosiin (apigenin-7-O-β-D-glucopyranoside, 12 mg, 10;
4
R
tR prep. HPLC, 36−38 min) [10]. Fractions eluted by 80−90% EtOH were separated by prep. HPLC [gradient mode (%B):
−60 min, 50−80%] to give cosmosiin 6″-O-ferulate (18 mg) [apigenin-7-O-(6″-O-feruloyl)-β-D-glucopyranoside, 11;
0
tR prep. HPLC, 40−42 min] [10]. The BuOH fraction (108 g) was separated using CC over polyamide (6 × 50 cm, eluent
H O−EtOH, 100:0→90:10). Fractions eluted by 10−20% EtOH were separated by prep. HPLC [gradient mode (%B):
2
0
−60 min, 0−30%, 60−80 min, 30−40%] to produce saponarin-2″-O-glucoside [apigenin-6-C-(2″-O-β-D-glucopyranosyl)-β-
D-glucopyranoside-7-O-β-D-glucopyranoside, 27 mg, 3; t prep. HPLC, 20−22 min] [5]; saponarin-2″-O-rhamnoside [apigenin-
R
6
-C-(2″-O-α-L-rhamnopyranosyl)-β-D-glucopyranoside-7-O-β-D-glucopyranoside, 16 mg, 4; t prep. HPLC, 23−24 min]
R
[
6]; and saponarin (apigenin-6-C-β-D-glucopyranoside-7-O-β-D-glucopyranoside, 22 mg, 5; t prep. HPLC, 24−25 min) [7].
R
The fraction eluted by 30% EtOH was recrystallized and rechromatographed over Sephadex LH-20 (CC, 2 × 70 cm, eluent
EtOH−H O, 80:20→30:70) to give isovitexin-2″-O-glucoside (37 mg) [apigenin-6-C-(2″-O-β-D-glucopyranosyl)-β-D-
2
glucopyranoside, 6] [8]. Fractions eluted by 50−70% EtOH were separated using prep. HPLC [gradient mode (%B):
0
−60 min, 10−40%, 60−100 min, 40−80%] and CC over Sephadex LH-20 (1 × 50 cm, eluent EtOH−H O, 90:10→30:70) to
2
isolate 2 (31 mg; t prep. HPLC, 30−32 min), isovitexin-2″-O-rhamnoside [apigenin-6-C-(2″-O-α-L-rhamnopyranosyl)-β-D-
R
glucopyranoside, 11 mg, 7; t prep. HPLC, 28−29 min] [9], isovitexin (apigenin-6-C-β-D-glucopyranoside, 14 mg, 8; t prep.
R
R
HPLC, 29−30 min) [7]; and saponarin 6″′-O-ferulate [apigenin-6-C-β-D-glucopyranoside-7-O-(6″′-O-feruloyl)-D-
glucopyranoside, 18 mg, 9; t prep. HPLC, 44−48 min] [7].
R
2
0
Divarioside A (1). C H O , mp 192–194°Ñ, [α] –92.4° (ñ 0.11, ÌåÎÍ). UV spectrum (ÌåÎÍ, λmax, nm): 271,
4
3
48 22
D
–
1
–
3
33. IR spectrum (ν, cm ): 1646, 1726. HR-ESI-MS, m/z 915.826 [M – H] (calcd 915.811 for C H O ). ESI-MS,
43 47 22
–
2
–
–
–
m/z: 915 [M – H] ; MS [915]: 769 [(M – H) – C H O ] , 739 [(M – H) – C H O ] , 593 [(M – H) – C H O – C H O ] ,
6
10
4
10
8
3
6
10
4
10 8 3
–
–
3
5
–
77 [(M – H) – C H O – C H O ] , 431 [(M – H) – C H O – C H O – C H O ] ; MS [431]: 341 [(M – H) – C H O
6 10 5 10 8 3 6 10 4 6 10 5 10 8 3 6 10 4
–
–
C H O – C H O – C H O ] , 313 [(M – H) – C H O – C H O – C H O – C H O – CO] , 311 [(M – H) –
6
10
5
10
8
3
3
6
3
6
10
4
6
10
5
10
8
3
3 6 3
–
–
C H O – C H O – C H O – C H O ] , 283 [(M – H) – C H O – C H O – C H O – C H O – CO] . Table 1 lists
6
10
4
6
10
5
10
8
3
4
8
4
6
10
4
6
10
5
10
8
3
4 8 4
1
3
the PMR spectrum (500 MHz, MeOH-d , δ, ppm). Table 2 lists the C NMR spectrum (125 MHz, MeOH-d , δ, ppm).
4
4
2
0
Divarioside B (2). C H O , mp 184–186°Ñ, [α] –33.0° (ñ 0.10, ÌåÎÍ). UV spectrum (ÌåÎÍ, λmax, nm): 270,
4
3
48 23
D
–
1
–
3
33. IR spectrum (ν, cm ): 1650, 1718. HR-ESI-MS, m/z 931.789 [Ì – Í] (calcd 931.810 for C H O ). ESI-MS,
43 47 23
–
2
–
–
–
m/z: 931 [M – H] ; MS [931]: 769 [(M – H) – C H O ] , 755 [(M – H) – C H O ] , 593 [(M – H) – C H O – C H O ] ,
6
10
5
10
8
3
6
10
5
10 8 3
–
3
–
4
2
–
31 [(M – H) – 2 × C H O – C H O ] ; MS [431]: 341 [(M – H) – 2 × C H O – C H O – C H O ] , 313 [(M – H) –
6 10 5 10 8 3 6 10 5 10 8 3 3 6 3
–
–
× C H O – C H O – C H O – CO] , 311 [(M – H) – 2 × C H O – C H O – C H O ] , 283 [(M – H) – 2 × C H O
6 10 5
6
10
5
10
8
3
3
6
3
6
10
5
10
8
3
4
8
4
–
13
C H O – C H O – CO] . Table 1 lists the PMR spectrum (500 MHz, MeOH-d , δ, ppm). Table 2 lists the C NMR
1
0
8
3
4
8
4
4
spectrum (125 MHz, MeOH-d , δ, ppm).
4
Acid Hydrolysis of 1 and 2. A weighed portion (7 mg) was heated with TFA (2 M, 4 mL) at 120°C for 2 h.
The hydrolysate was evaporated with MeOH to dryness under vacuum. The dry residue was dissolved in EtOH (50%, 2 mL)
and chromatographed over polyamide (3 g) with elution sequentially by H O (50 mL, eluate I) and EtOH (70%, 100 mL,
2
eluate II). Monosaccharides were isolated by derivatizing a portion of eluate I with 3-methyl-1-phenyl-2-pyrazolin-5-one as
before [22] and analyzing by analytical HPLC (conditions 1). Monosaccharides in eluate I were assigned as D- and L-isomers
using reductive amination with L-tryptophan [23] followed by analytical HPLC (conditions 2). Eluate II was analyzed using
1
3
C NMR spectroscopy and mass spectrometry. The hydrolysate of 1 contained isovitexin (8), D-glucose, L-rhamnose, and
ferulic acid; of 2, 8, D-glucose, and ferulic acid.
Alkaline Hydrolysis of 1 and 2. Aweighed portion (5 mg) was dissolved in MeOH (2 mL); treated with NaOH (2 M,
1
mL); incubated at 30°C for 40 min; neutralized with HCl (2 M); placed on an RP-SiO cartridge (5 g) that was preconditioned
2
with H O; and eluted with H O until the eluate was neutral, MeCN (40%, 50 mL eluate I), and MeCN (90%, eluate II).
2
2
The eluates were analyzed by HPLC (conditions 3) and mass spectrometry. The hydrolysate of 1 contained saponarin-2″-O-
rhamnoside (4, eluate I) [6] and ferulic acid (eluate II); of 2, saponarin-2″-O-glucoside (3, eluate I) [5] and ferulic acid (eluate II).
Hydrolysis of 1 and 2 by β-Glucosidase. A weighed portion (5 mg) was dissolved in DMSO (100 μL), adjusted to
2
mL using MeOH (30%), and treated with β-glucosidase [3.2.1.21, 30 U/mg, Sigma-Aldrich; 2 U in 500 μL of phosphate
buffer (100 mM, pH 5.0)]. The reaction mixture was incubated at 37°C for 10 h, heated to 95°C (15 min), and centrifuged
(
1
6,000 rpm, 15 min). The supernatant was chromatographed over polyamide (5 g) with elution by H O (50 mL), EtOH (30%,
2
00 mL, eluate I), and EtOH (70%, 100 mL, eluate II). The eluates were analyzed by HPLC (conditions 3), C NMR
1
3
1
036